Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Mirena: risk of uterine perforation

    • 22 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Bayer HealthCare Pharmaceuticals.Association of MIRENA(Rm) (levonorgestrel-releasing intrauterine system) with the potential risk of uterine perforation. Internet Document: [2 Pages], 15 Jun 2010. Available from: URL: http://www.hc-sc.gc.ca

    2. 2.

      Bayer HealthCare Pharmaceuticals.Association of MIRENA(Rm) (levonorgestrel-releasing intrauterine system) with the potential risk of uterine perforation. Internet Document: [2 Pages], 15 Jun 2010. Available from: URL: http://www.hc-sc.gc.ca

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Mirena: risk of uterine perforation. React. Wkly. 1307, 2 (2010). https://doi.org/10.2165/00128415-201013070-00003

    Download citation

    Keywords

    • Public Health
    • Potential Risk
    • Healthcare Professional
    • Health Care Professional
    • Absolute Number